Back to search

Company profile

PHAGENESIS LIMITED

active • ltd • Unit 18 Enterprise House, Pencroft Way, Manchester Science Park, Manchester, M15 6SE, England

Company no.06308699Officers24Documents20

Key company facts

Core operating details surfaced from the public profile endpoint.

Company Number
06308699
Company Status
active
Type
ltd
Date Of Creation
2007-07-10
Registered Office
Unit 18 Enterprise House, Pencroft Way, Manchester Science Park, Manchester, M15 6SE, England
Sic Codes
other research and experimental development on natural sciences and engineering

Financials

A cleaner view of the latest filing, balance sheet movement, and multi-year trend.

Total assets

£10.46m

Equity

£9.70m

Total liabilities

£764,043

Cash in bank

£9.38m

Year-on-year movement

Quick comparison from the latest filed period.

2024-12-31

Equity

+£34.70M

+138.78%

Cash in bank

+£8.88M

+1784.39%

Total assets

+£9.30M

+803.60%

Total liabilities

+£25.40M

+97.08%

Financial trend

Multi-year view of the main balance sheet lines.

Net Assets
Total Assets
Total Liabilities
20202021202220232024

Latest snapshot

Financial year2024
Statement date2024-12-31
Trade debtors£82,720
Trade creditors£182,610
Fixed assets£119,244
Current assets£10.34m
YearNet AssetsTotal AssetsTotal Liabilities
2020£0£0£0
2021-£13.31m£6.39m-£19.70m
2022£0£0£0
2023-£25.00m£1.16m-£26.16m
2024£9.70m£10.46m-£764,043

Available In The Full Platform

Unlock deeper company intelligence

More company intelligence is available through your account, including premium data, deeper records, and advanced insight.

Locked contact intelligence

Contact Details & Ownership

Reveal verified contact points, shareholder visibility, and group structure signals beyond the public summary.

Locked insight

Sign up or log in to view contact insight

Contact DetailsShareholdersGroup StructureCorporate Network Graph

Locked compliance screening

Risk & Compliance

Access enhanced due diligence signals for KYC, sanctions, adverse media, phoenix risk, and register visibility.

Locked insight

Sign up or log in to access compliance insight

KYC+Adverse Media ScreeningPhoenix Detection SummaryFCA Register

Locked financial insight

Financial Intelligence

Unlock premium financial analysis including credit insight, risk scoring, and AI-assisted valuation signals.

Locked insight

Sign up or log in to unlock financial insight

AI Financial Risk InsightsAI Company ValuationCredit ScoreCharges

Locked filing intelligence

Assets, Filings & Registers

Go beyond the headline profile with deeper asset, filing, register, and notice-level intelligence.

Locked insight

Sign up or log in to explore filing insight

PropertyTrademarkGazette NoticesCharges

Latest activity

Recent company and officer updates, reshaped from the watchlist activity source for public profile use.

UpdateDateRecency
Accounts Submitted23 Sep 20258 Months
Confirmation Statement Submitted22 Jul 202510 Months
GIBBONS, James, Dr. Appointed17 Oct 20241 Year
GIBBONS, James William Appointed17 Oct 20241 Year
WYATT, Mark Andrew, Dr Resigned3 Oct 20241 Year
KRICKL, Reinhard Resigned16 Aug 20241 Year
HOSKINS, Horace Appointed16 Aug 20241 Year
Confirmation Statement Submitted15 Jul 20241 Year
Accounts Submitted30 May 20241 Year
Accounts Submitted15 May 20242 Years
Confirmation Statement Submitted15 May 20242 Years
Change of Date Of Creation15 May 20242 Years

Documents

Public filing documents and direct PDF links where available.

DescriptionDateDocument
appoint-person-director-company-with-name-date2026-05-05Open PDF
capital-allotment-shares2026-05-05Open PDF
change-person-director-company-with-change-date2026-04-02Open PDF
capital-allotment-shares2025-12-11Open PDF
change-person-director-company-with-change-date2025-12-09Open PDF
capital-allotment-shares2025-11-24Open PDF
capital-allotment-shares2025-10-13Open PDF
notification-of-a-person-with-significant-control-statement2025-09-29Open PDF
cessation-of-a-person-with-significant-control2025-09-29Open PDF
accounts-with-accounts-type-small2025-09-23Open PDF
capital-allotment-shares2025-09-04Open PDF
capital-allotment-shares2025-09-02Open PDF